AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Title:
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Author:
O'Hare, Thomas Shakespeare, William C. Zhu, Xiaotian Eide, Christopher A. Rivera, Victor M. Wang, Frank Adrian, Lauren T. Zhou, Tianjun Huang, Wei-Sheng Xu, Qihong Metcalf III, Chester A. Tyner, Jeffrey W. Loriaux, Marc M. Corbin, Amie S. Wardwell, Scott Ning, Yaoyu Keats, Jeffrey A. Wang, Yihan Sundaramoorthi, Raji Thomas, Mathew Zhou, Dong Snodgrass, Joseph Commodore, Lois Sawyer, Tomi K. Dalgarno, David C. Deininger, Michael W.N. Druker, Brian J. Clackson, Tim